More about

Insulin-Like Growth Factor I

News
May 27, 2022
1 min read
Save

GH levels higher for postmenopausal women vs. men with controlled acromegaly

Among adults with controlled acromegaly, postmenopausal women had higher growth hormone levels than men despite similar insulin-like growth factor I levels, according to study data.

News
May 25, 2022
1 min read
Save

Low-dose ADHD drugs do not affect thyroid function, growth hormone at 1 year

Among children diagnosed with ADHD, low doses of ADHD medications did not affect thyroid or growth hormone levels, according to study data.

News
May 02, 2022
2 min read
Save

Vertebral fracture risk increased for adults with acromegaly, high growth hormone levels

Adults with acromegaly are more likely to experience a vertebral fracture than those without the disease, and high growth hormone levels increase fracture risk, according to study data from Italy.

News
August 10, 2021
3 min read
Save

Experts offer recommendations for management of pituitary tumors

An international panel reached consensus for pre- and postoperative endocrine testing to manage adults undergoing transsphenoidal surgery, including measurement of prolactin and insulin-like growth factor I levels for all pituitary tumors.

News
March 11, 2021
2 min read
Save

Cancer rate not elevated for adults with acromegaly

Adults treated for acromegaly at a medical center in Turkey do not have an increased risk for cancer compared with the general population, according to study findings published in Endocrine Practice.

News
October 23, 2020
2 min read
Save

Teprotumumab confers long-term benefits in thyroid eye disease

Adults with active thyroid eye disease assigned the human monoclonal antibody teprotumumab experienced improvements in disease outcomes that persisted nearly 1 year after receiving the last trial dose, new study data show.

News
March 30, 2020
3 min read
Save

Oral therapy shows promise as injection alternative for acromegaly

Adults with acromegaly assigned an investigational oral form of the somatostatin analogue octreotide maintained a biochemical response at 36 weeks achieved with previous injection therapy with no serious adverse events, according to findings from the OPTIMAL study accepted for presentation at the Endocrine Society Annual Meeting.

News
January 27, 2020
3 min read
Save

IGF-I level, age associated with mortality risk in acromegaly

Higher on-treatment serum insulin-like growth factor I levels may be associated with higher all-cause mortality risk among adults with acromegaly receiving the growth hormone blocker pegvisomant, according to findings from a worldwide database analysis.

News
November 22, 2019
3 min read
Save

Dairy, plant-based food consumption may impact risk for prostate cancer

Consumption of high amounts of dairy products appeared to be associated with increased risk for prostate cancer, according to results of a retrospective study published in The Journal of the American Osteopathic Association.

News
October 15, 2019
4 min read
Save

At-home therapy plus in-office treatment maximizes hair growth investment

by Deanne Mraz Robinson, MD

View more